Stockreport

Quanterix to Participate in the 15th Clinical Trials on Alzheimer’s Disease (CTAD) Task Force

Quanterix Corporation  (QTRX) 
US:NASDAQ Investor Relations: ir.quanterix.com/investor-relations
PDF Company to provide industry perspective on the use of emerging blood-based biomarkers tests in Alzheimer’s disease clinical trials. BILLERICA, Mass.--(BUSINESS WIRE)- [Read more]